Activities
The aim of the MedEA Academy is to provide high-quality medical education that supports healthcare professionals in their ongoing professional development and, ultimately, contributes to improving patient outcomes.
MedEA Academy delivers a wide range of educational activities, including CME Live Webinars, Video Interviews, and Podcasts, all developed to address the educational needs of healthcare professionals working in this field.
Educational activities focused on Growth Disorders are available in English, Spanish, and Korean.
Growth Disorders
Digital decision-making in the management of growth disorders
Marco Cappa, Italy; Paul Dimitri, UK; Paula van Dommelen, The Netherlands
Growth decoded: Managing pharmacogenomics and AI to transform hormone therapy predictions
Peter Clayton, UK
Sandro Loche, Italy
Arguments for the benefits of clinical skills in the diagnostic assessment of short stature
Justin Davies, UK; Helen Storr, UK
Growth Disorder Care – Practical Solutions for Investigating and Treating Children with ISS and the Contribution of Genetic Studies in the Investigation of Growth Disorders
Richard JM Ross, UK; Martin O. Savage, UK; Helen Storr, UK
+ More info
Imprinting Disorders: A Clinical Guide
Justin Davies, UK
+ More info
Artificial Intelligence (AI) in Paediatric Endocrinology: How does it Compare with Clinical Skills?
Paul Dimitri, UK
+ More info
Leadership in Paediatric Endocrinology: Lessons and Guidance
Wieland Kiess, Germany; Martin O. Savage, UK
+ More info
AI in growth disorders – opportunities and challenges
Paul Dimitri, UK
+ More info
Digital innovations to support nursing care of paediatric endocrine disorders
Laura Peltonen, Finland
+ More info
Clinical skills are essential for the accurate diagnosis of short stature
Martin O. Savage, UK
+ More info
E-health tools can make a key difference to outcome of therapy in growth disorders
Luis Fernandez-Luque, USA
+ More info
Priorities for an optimal response to Pediatric Growth Hormone (hGH)
Justin Davies, UK; Richard Ross, UK; Martin O. Savage, UK; John Weinman, UK; Cheri Deal, Canada; Marco Cappa, Italy
+ More info
Central Precocious Puberty (CPP)
Complex cases in precocious puberty
Sasha Howard, UK; Yoon Hi Cho, Australia
New developments in the treatment of CPP
Justin Davies, UK; Sasha Howard, UK; Rachel Varughese, UK
Updates on the diagnosis and management of CPP
Sasha Howard, UK
Genetic and environmental causes of central precocious puberty
Marco Cappa, Italy; Sasha Howard, UK
Update on metabolic alterations associated with the genetic diagnosis of central precocious puberty
Martin Savage, UK; Jesús Argente; Spain
Height outcomes in central precocious puberty treated with GnRH analogue therapy
Sasha Howard, UK; Han-Wook Yoo, Republic of Korea
Choice and initiation of GnRHa therapy for CPP with emphasis on long-acting administration
Martin O. Savage, UK; Karen Klein, USA
Early identification of CPP patients requiring GnRH analogue therapy
Martin O. Savage, UK; Anders Juul, Denmark
Awareness of CPP within the range of variations of growth and puberty in pediatric endocrine practice
Martin O. Savage, UK; Sasha Howard, UK